Baker Bros. Advisors’s Gilead Sciences GILD Stock Holding History

Baker Bros. Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-249,995	Closed	-$25.3M	–	135
2015 Q4	$25.3M	Hold	249,995	–	–	0.21%	35
2015 Q3	$24.5M	Hold	249,995	–	–	0.23%	33
2015 Q2	$29.3M	Hold	249,995	–	–	0.26%	38
2015 Q1	$24.5M	Sell	249,995 -6,113	-2%	-$621K	0.2%	40
2014 Q4	$24.1M	Hold	256,108	–	–	0.25%	36
2014 Q3	$27.3M	Hold	256,108	–	–	0.34%	29
2014 Q2	$21.2M	Sell	256,108 -300,000	-54%	-$23.4M	0.26%	35
2014 Q1	$39.4M	Hold	556,108	–	–	0.5%	29
2013 Q4	$41.8M	Sell	556,108 -689,692	-55%	-$48M	0.59%	25
2013 Q3	$78.3M	Hold	1,245,800	–	–	1.11%	13
2013 Q2	$63.9M	Buy	+1,245,800	New	+$64.9M	1.26%	12

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baker Bros. Advisors's GILD Position: Q1 2016 in Review

Baker Bros. Advisors sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 249,995 shares — an estimated $25.3M sold.

Baker Bros. Advisors first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $78.3M in Q3 2013. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Baker Bros. Advisors reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Baker Bros. Advisors sold 249,995 Gilead Sciences shares in Q1 2016, an estimated $25.3M.
Baker Bros. Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Baker Bros. Advisors's Gilead Sciences position peaked at $78.3M in Q3 2013.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Baker Bros. Advisors's 13F filing for Q1 2016, filed 16 May 2016.